EDGAR Filing Documents for 0001193125-06-131900

Form 8-K - Current report:

SEC Accession No. 0001193125-06-131900

Filing Date

2006-06-19

Accepted

2006-06-19 14:50:23

Documents

Period of Report

2006-06-14

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d8k.htm	8-K	14853
2	1999 EQUITY INCENTIVE PLAN	dex101.htm	EX-10.1	28410
3	TABULATION OF STOCKHOLDER VOTES	dex991.htm	EX-99.1	5344
	Complete submission text file	0001193125-06-131900.txt		50289

Mailing Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111

Business Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111 212-994-8200

ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)